Fuji Pharma Balance Sheet Health
Financial Health criteria checks 3/6
Fuji Pharma has a total shareholder equity of ¥42.0B and total debt of ¥21.5B, which brings its debt-to-equity ratio to 51.2%. Its total assets and total liabilities are ¥84.6B and ¥42.6B respectively. Fuji Pharma's EBIT is ¥2.5B making its interest coverage ratio 56.2. It has cash and short-term investments of ¥2.2B.
Key information
51.2%
Debt to equity ratio
JP¥21.48b
Debt
Interest coverage ratio | 56.2x |
Cash | JP¥2.16b |
Equity | JP¥41.98b |
Total liabilities | JP¥42.60b |
Total assets | JP¥84.58b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 4554's short term assets (¥40.4B) exceed its short term liabilities (¥27.7B).
Long Term Liabilities: 4554's short term assets (¥40.4B) exceed its long term liabilities (¥14.9B).
Debt to Equity History and Analysis
Debt Level: 4554's net debt to equity ratio (46%) is considered high.
Reducing Debt: 4554's debt to equity ratio has increased from 5.5% to 51.2% over the past 5 years.
Debt Coverage: 4554's debt is not well covered by operating cash flow (8.9%).
Interest Coverage: 4554's interest payments on its debt are well covered by EBIT (56.2x coverage).